Tag:
Cleveland Biolabs
Latest Headlines
Latest Headlines
Cleveland BioLabs shares tank after BARDA drops support
Shares of Cleveland BioLabs ($CBLI) were trounced yesterday as word spread that a division of Health and Human Services had turned a cold shoulder to its experimental treatment for radiation poisoning.
Cleveland BioLabs radiation drug ready for potential Japan use
Although Cleveland BioLabs has yet to receive FDA approval for its irradiation treatment CBLB502, or Protectan, the fast-tracked, orphan drug may be made available for Japanese workers who have been
Radiation treatment drug granted fast track status
Cleveland Biolabs' acute radiation syndrome drug, CBLB502, has received Fast Track status from the FDA. The drug, which would be used to treat patients who have been exposed to radiation from nuclear
